In conclusion, we analysed the myocardial metabolic, lipidomic and proteomic profile of a single cardiac biopsy of individuals affected with BTHS using a unified extraction providing high-quality data, confirming known BTHS aberrations in heart tissue, while also providing potentially new areas of interest. This evidence concerns the gene TAFAZZIN and Barth syndrome.